XCRP Stock Overview
Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Xcorporeal, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | -99.97% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| XCRP | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -4.4% | -3.7% |
| 1Y | n/a | -2.8% | 20.2% |
Return vs Industry: Insufficient data to determine how XCRP performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how XCRP performed against the US Market.
Price Volatility
| XCRP volatility | |
|---|---|
| XCRP Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: XCRP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine XCRP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | n/a | n/a |
Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs.
Xcorporeal, Inc. Fundamentals Summary
| XCRP fundamental statistics | |
|---|---|
| Market cap | US$15.00 |
| Earnings (TTM) | -US$2.97m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs XCRP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XCRP income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.97m |
| Earnings | -US$2.97m |
Last Reported Earnings
Sep 30, 2009
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did XCRP perform over the long term?
See historical performance and comparison